Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Federal Trade Commission
Moodys
Dow
Novartis
Healthtrust
Daiichi Sankyo
Medtronic
Cantor Fitzgerald
Cerilliant

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,129,433

« Back to Dashboard

Summary for Patent: 8,129,433
Title:Enterically coated cysteamine, cystamine and derivatives thereof
Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
Inventor(s): Dohil; Ranjan (San Diego, CA), Schneider; Jerry (La Jolla, CA)
Assignee: The Regents of the University of California (Oakland, CA)
Application Number:13/190,396
Patent Claim Types:
see list of patent claims
Composition; Delivery; Formulation;

Drugs Protected by US Patent 8,129,433

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,129,433

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 1919458 ➤ Sign Up
Portugal 1919458 ➤ Sign Up
Netherlands 300649 ➤ Sign Up
Mexico 2008009647 ➤ Sign Up
Luxembourg 92389 ➤ Sign Up
Israel 193044 ➤ Sign Up
Spain 2388310 ➤ Sign Up
European Patent Office 2535044 ➤ Sign Up
European Patent Office 1919458 ➤ Sign Up C300649 Netherlands ➤ Sign Up
European Patent Office 1919458 ➤ Sign Up CR 2014 00013 Denmark ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Federal Trade Commission
Teva
Chinese Patent Office
Fuji
Chubb
Argus Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot